DNAJC5 and malaria: This antigen formulated with theAS02 adjuvant induces CSP specific adaptive immune responses and protection againstinfection in controlled parasite challenge studies [2]–[5] as well in semi-immune adults,children and infants living in malaria-endemic regions [6]–[11].